Inc. (ADR)

Dmitry Balyasny Sees Potential in Array Biopharma Inc (ARRY), Dumps Valeant Pharmaceuticals Intl Inc (VRX) and Himax Technologies, Inc. (ADR) (HIMX)

Has this billion-dollar fund made the right call on ARRY, VRX, and HIMX?

Harriet Lefton Harriet Lefton — September 14, 2017, 9:36 AM EDT

Oppenheimer Sees Himax Technologies, Inc. (ADR) (HIMX) as an Overvalued Stock with Lost Growth Potential

Analyst warns that investors betting on Himax are naïve to bearish risks circling overhead.

Julie Lamb Julie Lamb — September 7, 2017, 2:06 PM EDT

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts